These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 35589257)

  • 21. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
    Hatton G; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
    [No Abstract]   [Full Text] [Related]  

  • 23. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What defines a healthy gut microbiome?
    Van Hul M; Cani PD; Petitfils C; De Vos WM; Tilg H; El-Omar EM
    Gut; 2024 Oct; 73(11):1893-1908. PubMed ID: 39322314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
    Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
    EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
    Woodhouse C; Singanayagam A; Patel VC
    Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebuilding the Gut Microbiota Ecosystem.
    Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.
    Kalam N; Balasubramaniam VRMT
    Postgrad Med J; 2024 Jul; 100(1186):539-554. PubMed ID: 38493312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and sepsis: from pathogenesis to novel treatments.
    Kullberg RFJ; Wiersinga WJ; Haak BW
    Curr Opin Gastroenterol; 2021 Nov; 37(6):578-585. PubMed ID: 34419965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health.
    Parker A; Fonseca S; Carding SR
    Gut Microbes; 2020; 11(2):135-157. PubMed ID: 31368397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.
    Bajaj JS; Khoruts A
    J Hepatol; 2020 May; 72(5):1003-1027. PubMed ID: 32004593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiome and non-alcoholic fatty liver disease.
    Purohit A; Alam MJ; Kandiyal B; Shalimar ; Das B; Banerjee SK
    Prog Mol Biol Transl Sci; 2022; 191(1):187-206. PubMed ID: 36270678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
    Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
    Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.